Search results
The FLiRT subvariants are rising: How bad will a California summer COVID wave get?
Los Angeles Times· 3 days agoWhile California’s COVID numbers look relatively good, officials say FLiRT’s rise shows the need to...
The Push to Get More People Into Long COVID Studies
Medscape· 14 hours agoWhen Ezra Spier was diagnosed with long COVID in late 2022, his main symptom, postexertional malaise, caused fatigue so severe that it forced him to quit...
Dr. Anthony Fauci testifies before House panel over COVID-19 origins, pandemic response
AOL· 1 day agoIn his first public appearance on Capitol Hill in nearly two years, Dr. Anthony Fauci testified before a Republican-led House panel Monday over the possible origins of COVID
As states loosen childhood vaccine requirements, health experts’ worries grow
KPVI· 5 days agoAn infant in Fayetteville, Ga., receives one of several routine vaccinations typically required for...
US Nears Deal To Fund Moderna mRNA Bird Flu Shot Trial, Report Says
Forbes· 6 days agoCiting unnamed people close to the discussion, the Financial Times reported federal funding worth...
Moderna nears deal with US government to receive funding for bird flu vaccine, report says - The...
The Boston Globe· 5 days agoModerna is nearing a deal with the US government to fund a late-stage trial of its bird flu vaccine,...
Analysis | Four questions for today’s Fauci hearing
Washington Post· 1 day agoThe Texas Supreme Court rejected a lawsuit that sought to clarify exceptions to the state’s abortion laws. The longtime infectious-disease expert is back...
Minnesota Republican Royce White’s Failed Campaign Spent $1,200 at a “Full-Nude” Strip Club
Esquire· 5 days agoThe Star Tribune revealed that records from White’s 2022 congressional campaign showed some...
Ocugen stock price analysis: good progress but a risky pattern forms | Invezz
Invezz· 6 days agoIt has soared by over 177% this year, outperforming the S&P 500, Nasdaq 100, and the iShars...
Is Pfizer the Best Dividend Stock for You?
Motley Fool via Yahoo Finance· 4 days agoPFE Revenue (TTM) data by YCharts Pfizer's vaccine (Comirnaty) and treatment option (Paxlovid) combined for $56 billion in revenue in 2022. Those two...
